Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.
Ruan R, Li L, Li X, Huang C, Zhang Z, Zhong H, Zeng S, Shi Q, Xia Y, Zeng Q, Wen Q, Chen J, Dai X, Xiong J, Xiang X, Lei W, Deng J.
Ruan R, et al. Among authors: zhang z.
Mol Cancer. 2023 Mar 25;22(1):60. doi: 10.1186/s12943-023-01761-7.
Mol Cancer. 2023.
PMID: 36966334
Free PMC article.
Review.